target-controlled infusion plasma concentration of propofol (Tokyo Chemical Industry)
90
Structured Review
Tokyo Chemical Industry
target-controlled infusion plasma concentration of propofol
Target Controlled Infusion Plasma Concentration Of Propofol, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target-controlled+infusion+plasma+concentration+of+propofol/plasma+concentration+of+propofol/pm40439868-10-14-9
Average 90 stars, based on 1 article reviews
Target Controlled Infusion Plasma Concentration Of Propofol, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/target-controlled+infusion+plasma+concentration+of+propofol/plasma+concentration+of+propofol/pm40439868-10-14-9
Average 90 stars, based on 1 article reviews
target-controlled infusion plasma concentration of propofol - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Clinical Proteomics:Article Title: Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake transition and hemodynamic stability during propofol, dexmedetomidine, and remifentanil anesthesia. Article Snippet: 1 Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, 132 Waihuan Dong Road, Guangzhou, Guangdong 510006, China 2 Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou, Guangdong 510080, China 3 Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yatsen University, Guangzhou, Guangdong, China 4 Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China 5 Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China 6 Department of Pharmacy, Shenzhen Second People’s Hospital, Shenzhen, Guangdong, China Abstract Background Propofol-remifentanil-dexmedetomidine-based total intravenous anesthesia is widely utilized in clinical practice.. However, maintaining safety during the sleep-wake transition and ensuring hemodynamic stability continues to pose significant challenges.. This study aimed to investigate the impact of genes that are expressed specifically in orexinergic neurons on interindividual variability in the time to loss of consciousness (LOC), time to wake, and cardiovascular fluctuations. Concentration Assay:Article Title: Combined effects of HCRTR1/2 gene variants and non-genetic factors on sleep-wake transition and hemodynamic stability during propofol, dexmedetomidine, and remifentanil anesthesia. Article Snippet: 1 Institute of Clinical Pharmacology, School of Pharmaceutical Sciences, Sun Yat-sen University, 132 Waihuan Dong Road, Guangzhou, Guangdong 510006, China 2 Department of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou, Guangdong 510080, China 3 Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yatsen University, Guangzhou, Guangdong, China 4 Department of Pharmacy, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China 5 Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China 6 Department of Pharmacy, Shenzhen Second People’s Hospital, Shenzhen, Guangdong, China Abstract Background Propofol-remifentanil-dexmedetomidine-based total intravenous anesthesia is widely utilized in clinical practice.. However, maintaining safety during the sleep-wake transition and ensuring hemodynamic stability continues to pose significant challenges.. This study aimed to investigate the impact of genes that are expressed specifically in orexinergic neurons on interindividual variability in the time to loss of consciousness (LOC), time to wake, and cardiovascular fluctuations. |